Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent

J Surg Oncol. 2014 Mar;109(3):270-4. doi: 10.1002/jso.23481. Epub 2013 Oct 28.

Abstract

Background and objectives: Electrochemotherapy (ECT) is technique for local control of skin metastasis. This study is primarily aimed at assessing the clinical activity of ECT in a prospective cohort of patients, and evaluating the association between primary tumor histology, number of metastatic lesions and size of tumor deposits and objective response rate.

Methods and results: Thirty-nine patients with skin metastases from melanoma and other tumors underwent intravenous bleomycin ECT with palliative intent. No serious adverse events (SAE) or CTC grade 3 or 4 were observed. Overall response rate (ORR) was 66.6%. Response rate significantly correlated at univariate analysis both with the number (< or >10) and the size (< or >2 cm) of metastases. No relationship was observed for the histology of primary tumor. At multivariate analysis the size of the nodules under 2 cm was associated with a positive response and the correlation was statistically significant.

Conclusions: ORR was 66.6% and all patients obtained a subjective clinical benefit from the treatment with minimal side effects. The most suitable patients were the ones with nodules <2 cm.

Keywords: bleomycin; electrochemotherapy; electroporation; in-transit metastases; melanoma.

Publication types

  • Clinical Trial

MeSH terms

  • Adenocarcinoma / drug therapy
  • Adenocarcinoma / secondary
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / pathology
  • Carcinoma, Basal Cell / drug therapy
  • Carcinoma, Basal Cell / secondary
  • Carcinoma, Merkel Cell / drug therapy
  • Carcinoma, Merkel Cell / secondary
  • Carcinoma, Squamous Cell / drug therapy
  • Carcinoma, Squamous Cell / secondary
  • Electrochemotherapy* / methods
  • Female
  • Hemangiosarcoma / drug therapy
  • Hemangiosarcoma / secondary
  • Humans
  • Male
  • Melanoma / drug therapy
  • Melanoma / secondary
  • Middle Aged
  • Multivariate Analysis
  • Palliative Care / methods*
  • Prospective Studies
  • Sarcoma, Kaposi / drug therapy
  • Sarcoma, Kaposi / secondary
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / secondary*
  • Stomach Neoplasms / pathology
  • Treatment Outcome